Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 69

Results For "Citi"

703 News Found

RDIF and Morepen announce production of test batch of Sputnik V
News | July 08, 2021

RDIF and Morepen announce production of test batch of Sputnik V

The first batch will be shipped to the Gamaleya Center for the quality control


Ajooni Biotech to establish first Oxygen Park in Punjab
News | July 05, 2021

Ajooni Biotech to establish first Oxygen Park in Punjab

Oxygen Park is a concept where a two-layer layout is being used to plant oxygen releasing trees which releases oxygen for 24 hours


Dr. Reddy's announces commercial launch of 2DG
News | June 29, 2021

Dr. Reddy's announces commercial launch of 2DG

2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy's


'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.
Interviews | June 10, 2021

'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.

In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:


Trials of three more vaccines are in advanced stage: Modi
News | June 08, 2021

Trials of three more vaccines are in advanced stage: Modi

The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age


Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
News | May 26, 2021

Zydus and TLC sign agreement to market Liposomal Amphotericin B in India

With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage


Govt. monitoring supply of COVID-19 essential drugs
News | May 21, 2021

Govt. monitoring supply of COVID-19 essential drugs

Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.


Govt. to augment Covaxin production by 10 crore doses
News | May 16, 2021

Govt. to augment Covaxin production by 10 crore doses

Financial support is being provided as a grant from the Government of India


Cipla signs agreement with Lilly to expand access to COVID-19 treatment in India
News | May 10, 2021

Cipla signs agreement with Lilly to expand access to COVID-19 treatment in India

Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO)


Lupin enters into agreement with Lilly to expand access for COVID-19
News | May 10, 2021

Lupin enters into agreement with Lilly to expand access for COVID-19

Baricitinib is an oral medication that was earlier registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.